Clicky

Immutep Ltd(PRRUF) News

Date Title
Jul 29 3 ASX Penny Stocks With Market Caps Under A$400M To Watch
Jul 29 Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the 2025 World Conference on Lung Cancer
Jul 28 Immutep Announces Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
Jul 24 High Growth Tech Stocks To Watch In Australia July 2025
Jul 22 High Growth Tech Stocks in Australia for July 2025
Jul 21 Exploring Three High Growth Tech Stocks in Australia
Jul 20 High Growth Tech Stocks in Australia Featuring Life360 and Two Others
Jun 19 Exploring Life360 And 2 Prominent High Growth Tech Stocks In Australia
Feb 11 Is Immutep Limited (IMMP) the Best Long Term ASX Stock to Buy Now?
Oct 10 Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit
Jul 31 Immutep Quarterly Activities Report Q4 FY24
Apr 24 Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?
Apr 24 Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
Feb 5 10 Best Australian Stocks To Buy
Dec 21 Immutep Receives Constructive Regulatory Feedback on TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
Dec 7 Immutep Receives A$2.6 million R&D Tax Incentive from French Government
Nov 27 Immutep (ASX:IMM) investors are sitting on a loss of 22% if they invested five years ago
Apr 27 Immutep Quarterly Activities Report
Apr 26 Immutep Announces Presentation of New TACTI-002 Data at the 2023 ASCO Annual Meeting
Apr 26 Immutep Appoints Dr. Florian Vogl as Chief Medical Officer